Literature DB >> 10748187

ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK.

Y Yung1, Z Yao, T Hanoch, R Seger.   

Abstract

We identified a 46-kDa ERK, whose kinetics of activation was similar to that of ERK1 and ERK2 in most cell lines and conditions, but showed higher fold activation in response to osmotic shock and epidermal growth factor treatments of Ras-transformed cells. We purified and cloned this novel ERK (ERK1b), which is an alternatively spliced form of ERK1 with a 26-amino acid insertion between residues 340 and 341 of ERK1. When expressed in COS7 cells, ERK1b exhibited kinetics of activation and kinase activity similar to those of ERK1. Unlike the uniform pattern of expression of ERK1 and ERK2, ERK1b was detected only in some of the tissues examined and seems to be abundant in the rat and human heart. Interestingly, in Ras-transformed Rat1 cells, there was a 7-fold higher expression of ERK1b, which was also more responsive than ERK1 and ERK2 to various extracellular treatments. Unlike ERK1 and ERK2, ERK1b failed to interact with MEK1 as judged from its nuclear localization in resting cells overexpressing ERK1b together with MEK1 or by lack of coimmunoprecipitation of the two proteins. Thus, ERK1b is a novel 46-kDa ERK isoform, which seems to be the major ERK isoform that responds to exogenous stimulation in Ras-transformed cells probably due to its differential regulation by MEK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748187     DOI: 10.1074/jbc.M910060199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

2.  Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.

Authors:  Simone Kiermayer; Ricardo M Biondi; Jochen Imig; Guido Plotz; Jörg Haupenthal; Stefan Zeuzem; Albrecht Piiper
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

Review 3.  Protein-protein interactions in the regulation of the extracellular signal-regulated kinase.

Authors:  Dana Chuderland; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

Review 4.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

5.  Extracellular signal-regulated kinase 1c (ERK1c), a novel 42-kilodalton ERK, demonstrates unique modes of regulation, localization, and function.

Authors:  Daniel M Aebersold; Yoav D Shaul; Yuval Yung; Nirit Yarom; Zhong Yao; Tamar Hanoch; Rony Seger
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Distinct signalling particles containing ERK/MEK and B-Raf in PC12 cells.

Authors:  Matt MacCormick; Tanja Moderscheim; Louise W M van der Salm; Anna Moore; Shona Clements Pryor; Gretchen McCaffrey; Mark L Grimes
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies.

Authors:  Joseph Friedman; Sarah Kraus; Yirmi Hauptman; Yoni Schiff; Rony Seger
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

9.  SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.

Authors:  Raja R Sivalenka; Manoj Sinha; Rolf Jessberger
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

10.  Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade.

Authors:  Yoav D Shaul; Gilad Gibor; Alexander Plotnikov; Rony Seger
Journal:  Genes Dev       Date:  2009-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.